Antimicrobial Resistance (AMR) is among the top 10 global public health threats, according to WHO. In 2021, AMR was responsible for one death every 45 seconds, and if unchecked, it could lead to one death every 3 seconds by 2050. Infections are a major concern in ICUs, affecting 60–80% of patients with serious conditions like catheter-related bloodstream infections, ventilator-associated pneumonia, and catheter-associated urinary tract infections.
150 M affected
1B affected 1.5 M died
Trachoma leads blindness in 1.9 M people death
49 M affected 11 M died
2.5 M affected 6 L children died
Catheter, NG/NJ, tube/bedside/centreline/ventilator associated pneumonia, blood stream infection/surgical site
With RAMJA’s cutting-edge technology, physicians can now prescribe the right antibiotics at the right time—no lab wait required. We offer the world’s first ultra-fast, paper-based electrochemical DNA biosensor, detecting infections and antimicrobial resistance (AMR) in just 90 minutes. Our unique 3D DNA sandwich structure and redox-based detection enable fast, accurate, and affordable diagnostics—no complex labs or trained personnel needed. RAMJA Genosensor is redefining rapid diagnostics for better, faster patient care.
90-Minute Results for UTIs, Sepsis & More
Targeted Antibiotics via Pathogen-Specific Detection
Cuts Infrastructure Costs by 95% and Staffing Needs by 80%
Simple Operation for Technicians, Perfect for Low-Resource Settings
RAMJA GENOSENSOR has developed a fast, simple, and cost-effective solution for all hospitals, laboratories, and remote areas: a noble paper-based system that detects microbial infection and antimicrobial resistance within 2 hours
Buy Now
Nanoshot kills 99.9% of germs within minutes and provides 96-hour protection with a single, lab-validated, patented application.
